ACM
NTUS

AlphaCrest Capital Management’s Natus Medical Inc NTUS Stock Holding History

AlphaCrest Capital Management’s Portfolio NTUS Stock Details NTUS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-41,327
Closed -$1.36M – 1352
2019
Q4 		$1.36M Buy
41,327
+16,327
+65% +$523K 0.11% 218
2019
Q3 		$796K Buy
25,000
+12,900
+107% +$376K 0.05% 693
2019
Q2 		$311K Sell
12,100
-1,900
-14% -$48.4K 0.03% 851
2019
Q1 		$355K Buy
+14,000
New +$418K 0.05% 593

Other funds holding NTUS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
SAM
Silvercrest Asset Management New York $13.8B AUM 28.39% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
CRM
Cramer Rosenthal McGlynn Stamford, Connecticut $1.36B AUM 31.72% 1-Year Est. Return

AlphaCrest Capital Management's NTUS Position: Q1 2020 in Review

AlphaCrest Capital Management sold out of Natus Medical Inc (NTUS) in Q1 2020, closing a stake of 41,327 shares — an estimated $1.36M sold.

AlphaCrest Capital Management first reported a position in NTUS in Q1 2019 and held it in 4 quarters. The position peaked at $1.36M in Q4 2019. 166 funds tracked by Wall St. Rank hold NTUS as of Q1 2020.

  • AlphaCrest Capital Management reported no remaining Natus Medical Inc position as of Q1 2020 after selling out during the quarter.
  • AlphaCrest Capital Management sold 41,327 Natus Medical Inc shares in Q1 2020, an estimated $1.36M.
  • AlphaCrest Capital Management first reported a position in Natus Medical Inc in Q1 2019 and held it in 4 quarters.
  • AlphaCrest Capital Management's Natus Medical Inc position peaked at $1.36M in Q4 2019.
  • 166 funds tracked by Wall St. Rank held Natus Medical Inc as of Q1 2020.

Based on AlphaCrest Capital Management's 13F filing for Q1 2020, filed 13 May 2020.